GAP-Net site, Clarity Clinical Research, was featured on CNYCentral about their participation in the Bio-Hermes study.
Clarity Clinical Research, a Syracuse research group, is looking for volunteers in an Alzheimer’s risk study.
The study includes three visits with no-cost amyloid PET scans that are designed to predict or possibly diagnose Alzheimer’s disease. Brain amyloid plaques are sticky “clumps” of protein that build up around brain nerve cells and disrupt healthy brain activity.
Over 1,000 people will be able to participate nationwide, with Clarity Clinical Research selected as one of the first sites in the U.S. to enroll patients.
The study will also require research sites to have at least 20 percent of participants from a minority group. Lisa Sonneborn, the site director at Clarity Clinical Research, says most studies in this field include a small number of minorities, something that does not reflect the patients being treated for the disease.
“African Americans are about twice as likely as whites to develop Alzheimer’s disease, and Hispanics are about one-and-a-half times as likely. However, these high-risk populations are underrepresented in clinical studies,” said Sonneborn.
To qualify, you must be between the ages of 60 and 85 with or without memory concerns and you must have someone who can participate with you as a study partner.
To apply, visit clarityclinicalresearch.com or call 315-760-5905.
The group has received 250 calls already and they ask for applicants to be patient in getting a response.
Originally posted on CNYCentral.com on April 27, 2021.